{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:13:18Z","timestamp":1787605998981,"version":"build-2736575974"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>There have only been 3 efficacy trials reporting head-to-head comparisons of pharmacotherapy and trauma-focused psychotherapy for posttraumatic stress disorder (PTSD), and none were conducted in primary care. In addition, few trials have examined treatment sequences for patients not responding to an initial treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To test the hypothesis that (1) brief trauma-focused psychotherapy (written exposure therapy [WET]) is more effective than a choice of 3 selective serotonin reuptake inhibitors (SSRIs; ie, sertraline, fluoxetine, or paroxetine) and (2) WET augmentation is more effective than switching to the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine for those not responding to an SSRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a pragmatic comparative effectiveness trial conducted from April 2021 to June 2024 that randomized primary care patients to 1 of 3 treatment sequences: (1) SSRI followed by WET augmentation, (2) SSRI followed by switch to SNRI, or (3) WET followed by SSRI. Effectiveness in this pragmatic trial depends on treatment engagement and treatment fidelity. The study included patients meeting clinical criteria for PTSD from primary care clinics of 7 federally qualified health centers and 8 Department of Veterans Affairs medical centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>SSRI followed by WET augmentation, SSRI followed by switch to SNRI, or WET followed by SSRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      PTSD symptom severity, as measured by the\n                      <jats:italic>DSM-5<\/jats:italic>\n                      PTSD Checklist (PCL-5).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 700 patients (mean [SD] age, 45.1 [15.4] years; 368 men [62.1%]). The mean (SD) baseline PCL-5 score was 52.8 (11.1), indicating considerable symptom severity. At 4 months, 144 of 278 patients (51.8%) randomized to an SSRI were adherent and reported a 14.0-point PCL-5 decrease, whereas 111 of 352 patients (31.5%) randomized to WET completed all sessions and reported a 12.1-point decrease. There was no significant between-group difference (adjusted mean difference [MD],\u20091.79; 95% CI, \u22120.76 to 4.34;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.17). For the 122 of 295 patients (41.4%) randomized to an SSRI who did not respond to treatment, those randomized to switch to the SNRI reported a 9.2-point PCL-5 decrease compared with a 2.3-point decrease for those randomized to WET augmentation, which was a statistically significant between-group difference (adjusted MD,\u200910.19; 95% CI, 4.97-15.41;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Study results showed that treatment of PTSD in primary care with either SSRIs or WET was feasible and effective. For patients not responding to an SSRI, switching to an SNRI may be more effective than WET augmentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT04597190\">NCT04597190<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2025.2962","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:00:41Z","timestamp":1760540441000},"page":"1203","source":"Crossref","is-referenced-by-count":8,"title":["Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder"],"prefix":"10.1001","volume":"82","author":[{"given":"John C.","family":"Fortney","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"},{"name":"VA Health Systems Research, Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Kaysen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Public Mental Health & Population Sciences, School of Medicine, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Engel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"},{"name":"VA Health Systems Research, Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Cerimele","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John P.","family":"Nolan","sequence":"additional","affiliation":[{"name":"El Dorado, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Chase","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany E.","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hauge","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Bechtel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Population Health, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Taylor","sequence":"additional","affiliation":[{"name":"Primary Care Behavioral Health, VA Bedford Healthcare System, Bedford, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Acierno","sequence":"additional","affiliation":[{"name":"Ralph H Johnson VA Healthcare System, Charleston, South Carolina"},{"name":"Faillace Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nagel","sequence":"additional","affiliation":[{"name":"Primary Care Mental Health Integration, Cincinnati VA Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Sripada","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"},{"name":"VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Painter","sequence":"additional","affiliation":[{"name":"Health Systems Research Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, North Little Rock"},{"name":"Division of Pharmaceutical Evaluation & Policy, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryann B.","family":"DeBeer","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Denver"},{"name":"VA Rocky Mountain Mental Illness, Research, Education, and Clinical Center for Suicide Prevention, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Zimberoff","sequence":"additional","affiliation":[{"name":"HealthPoint SeaTac, SeaTac, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Bluett","sequence":"additional","affiliation":[{"name":"Family Medicine Residency, University of Montana, Missoula"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Oregon Health & Science University, Portland"},{"name":"Health Systems Research, Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Morland","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of San Diego, San Diego, California"},{"name":"VA San Diego Healthcare System, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Grubbs","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of San Diego, San Diego, California"},{"name":"VA San Diego Healthcare System, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Sloan","sequence":"additional","affiliation":[{"name":"National Center for PTSD at VA Boston Healthcare System, Boston, Massachusetts"},{"name":"Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Marx","sequence":"additional","affiliation":[{"name":"National Center for PTSD at VA Boston Healthcare System, Boston, Massachusetts"},{"name":"Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Heagerty","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"yoi250052r1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cct.2014.04.005","article-title":"Design of the Violence and Stress Assessment (ViStA) study: a randomized controlled trial of care management for PTSD among predominantly Latino patients in safety net health centers.","volume":"38","author":"Meredith","year":"2014","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"yoi250052r2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/HRP.0000000000000136","article-title":"The Prevalence of Posttraumatic Stress Disorder in Primary Care: A Systematic Review.","volume":"25","author":"Spottswood","year":"2017","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"yoi250052r6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/archpsyc.62.6.629","article-title":"Twelve-month use of mental health services in the US: results from the National Comorbidity Survey Replication.","volume":"62","author":"Wang","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"yoi250052r7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.brat.2012.07.001","article-title":"Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors.","volume":"50","author":"Sloan","year":"2012","journal-title":"Behav Res Ther"},{"issue":"3","key":"yoi250052r8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamapsychiatry.2017.4249","article-title":"A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial.","volume":"75","author":"Sloan","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"yoi250052r9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jamapsychiatry.2023.2810","article-title":"Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: a randomized clinical trial.","volume":"80","author":"Sloan","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"yoi250052r10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/jts.21858","article-title":"Written exposure therapy for veterans diagnosed with PTSD: a pilot study.","volume":"26","author":"Sloan","year":"2013","journal-title":"J Trauma Stress"},{"issue":"7","key":"yoi250052r11","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD Psychopharmacology Working Group.","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"9","key":"yoi250052r12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/jamapsychiatry.2019.0951","article-title":"Comparative efficacy and acceptability of pharmacological, psychotherapeutic, and combination treatments in adults with posttraumatic stress disorder: a network meta-analysis.","volume":"76","author":"Merz","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"yoi250052r13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1176\/appi.ajp.2018.17090995","article-title":"Doubly randomized preference trial of prolonged exposure vs sertraline for treatment of PTSD.","volume":"176","author":"Zoellner","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi250052r14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamapsychiatry.2018.3412","article-title":"Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial.","volume":"76","author":"Rauch","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi250052r15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4088\/JCP.v68n0105","article-title":"A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance.","volume":"68","author":"van der Kolk","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi250052r16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s13063-021-05517-w","article-title":"Zelen design clinical trials: why, when, and how.","volume":"22","author":"Simon","year":"2021","journal-title":"Trials"},{"issue":"12","key":"yoi250052r17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3928\/00485713-20081201-10","article-title":"Intent-to-treat vs. non\u2013intent-to-treat analyses under treatment nonadherence in mental health randomized trials.","volume":"38","author":"Ten Have","year":"2008","journal-title":"Psychiatr Ann"},{"issue":"173","key":"yoi250052r18","first-page":"1","article-title":"Integration of mental health\/substance abuse and primary care.","author":"Butler","year":"2008","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"issue":"4","key":"yoi250052r20","first-page":"156","article-title":"Behavioral health and the medical cost offset effect: current status, key concepts, and future applications.","volume":"10","author":"Strosahl","year":"1996","journal-title":"HMO Pract"},{"issue":"2","key":"yoi250052r21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10880-017-9516-9","article-title":"Toward a unified integration approach: uniting diverse primary care strategies under the Primary Care Behavioral Health (PCBH) model.","volume":"25","author":"Sandoval","year":"2018","journal-title":"J Clin Psychol Med Settings"},{"issue":"2","key":"yoi250052r22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1037\/a0020261","article-title":"The White River model of colocated collaborative care: a platform for mental and behavioral health care in the medical home.","volume":"28","author":"Pomerantz","year":"2010","journal-title":"Fam Syst Health"},{"issue":"2","key":"yoi250052r23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1037\/a0020341","article-title":"Primary care mental health integration in health care in the Department of Veterans Affairs.","volume":"28","author":"Pomerantz","year":"2010","journal-title":"Fam Syst Health"},{"issue":"10","key":"yoi250052r25","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s11606-016-3703-5","article-title":"The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample.","volume":"31","author":"Prins","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"10","key":"yoi250052r26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1037\/pas0000258","article-title":"Psychometric properties of the Posttraumatic Diagnostic Scale for DSM-5 (PDS-5).","volume":"28","author":"Foa","year":"2016","journal-title":"Psychol Assess"},{"issue":"11","key":"yoi250052r27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1037\/pas0000254","article-title":"Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans.","volume":"28","author":"Bovin","year":"2016","journal-title":"Psychol Assess"},{"issue":"6","key":"yoi250052r28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/jts.22975","article-title":"Minimal important difference metrics and test-retest reliability of the PTSD Checklist for DSM-5 with a primary care sample.","volume":"36","author":"Blanchard","year":"2023","journal-title":"J Trauma Stress"},{"issue":"10","key":"yoi250052r30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/da.22825","article-title":"Long-term treatment gains of a brief exposure-based treatment for PTSD.","volume":"35","author":"Thompson-Hollands","year":"2018","journal-title":"Depress Anxiety"},{"issue":"1","key":"yoi250052r31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1467-9531.2007.00180.x","article-title":"4. Regression with missing Ys: an improved strategy for analyzing multiply imputed data.","volume":"37","author":"Von Hippel","year":"2007","journal-title":"Sociol Methodol"},{"issue":"1","key":"yoi250052r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36921","article-title":"Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: a randomized clinical trial.","volume":"5","author":"Schnurr","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"yoi250052r34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archgenpsychiatry.2011.25","article-title":"Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.","volume":"68","author":"Craske","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi250052r35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11606-012-2166-6","article-title":"RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial.","volume":"28","author":"Schnurr","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"1","key":"yoi250052r36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamapsychiatry.2014.1575","article-title":"Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial.","volume":"72","author":"Fortney","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"yoi250052r37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamainternmed.2016.2402","article-title":"Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial.","volume":"176","author":"Engel","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"4","key":"yoi250052r38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1037\/fsh0000315","article-title":"Moving effective treatment for posttraumatic stress disorder to primary care: a randomized controlled trial with active duty military.","volume":"35","author":"Cigrang","year":"2017","journal-title":"Fam Syst Health"},{"issue":"5","key":"yoi250052r39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1037\/tra0001148","article-title":"Effectiveness of written exposure therapy for posttraumatic stress disorder in the Department of Veterans Affairs health care system.","volume":"15","author":"LoSavio","year":"2023","journal-title":"Psychol Trauma"},{"key":"yoi250052r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2024.107435","article-title":"Design of a hybrid implementation effectiveness cluster randomized controlled trial of delivering written exposure therapy for PTSD in underserved primary care settings.","volume":"138","author":"Meredith","year":"2024","journal-title":"Contemp Clin Trials"},{"key":"yoi250052r41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.genhosppsych.2022.03.009","article-title":"Deploying a telemedicine collaborative care intervention for posttraumatic stress disorder in the US Department of Veterans Affairs: a stepped wedge evaluation of an adaptive implementation strategy.","volume":"77","author":"Fortney","year":"2022","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"yoi250052r42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s10865-013-9527-4","article-title":"Motivational interviewing with primary care populations: a systematic review and meta-analysis.","volume":"37","author":"VanBuskirk","year":"2014","journal-title":"J Behav Med"},{"issue":"1","key":"yoi250052r43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002795.pub2","article-title":"Pharmacotherapy for posttraumatic stress disorder (PTSD).","volume":"2006","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"yoi250052r44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1176\/appi.ps.201700067","article-title":"A comparison of collaborative care outcomes in 2 health care systems: VA clinics and federally qualified health centers.","volume":"69","author":"Grubbs","year":"2018","journal-title":"Psychiatr Serv"},{"key":"yoi250052r45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cpr.2015.06.008","article-title":"The efficacy of recommended treatments for veterans with PTSD: a meta-regression analysis.","volume":"40","author":"Haagen","year":"2015","journal-title":"Clin Psychol Rev"},{"issue":"6","key":"yoi250052r46","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.4088\/JCP.12r08225","article-title":"Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.","volume":"74","author":"Watts","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"yoi250052r47","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2025.102976","article-title":"A meta-analytic review of cognitive processing therapy with and without the written account.","volume":"110","author":"Sager","year":"2025","journal-title":"J Anxiety Disord"},{"issue":"3","key":"yoi250052r48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/adb0000355","article-title":"Alcohol, cannabis, and other drug use: Engagement and outcome in PTSD treatment.","volume":"32","author":"Bedard-Gilligan","year":"2018","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"yoi250052r49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.","volume":"26","author":"Davidson","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"yoi250052r3","volume-title":"Clinical Practice Guideline. Management of Posttraumatic Stress Disorder and Acute Stress Disorder Work Group","author":"Veterans Administration\/Department of Defense","year":"2023"},{"key":"yoi250052r19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-0-387-32973-4_1","volume-title":"Behavioral Consultation and Primary Care: A Guide to Integrating Services","author":"Robinson","year":"2007"},{"key":"yoi250052r29","doi-asserted-by":"crossref","DOI":"10.1037\/0000441-000","volume-title":"Written Exposure Therapy for PTSD: A Brief Treatment Approach for Mental Health Professionals","author":"Sloan","year":"2025","edition":"2nd ed"},{"key":"yoi250052r4","unstructured":"American_Psychological_Association. APA clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. Accessed May 23, 2025. https:\/\/www.apa.org\/ptsd-guideline"},{"key":"yoi250052r5","unstructured":"International_Society_for_Traumatic_Stress_Studies. New ISTSS prevention and treatment guidelines. Accessed February 11, 2025. https:\/\/istss.org\/wp-content\/uploads\/2024\/08\/ISTSS_PreventionTreatmentGuidelines_FNL-March-19-2019.pdf"},{"key":"yoi250052r24","unstructured":"HRSA Data Warehouse. Health Center Program Uniform Data System (UDS) data overview. Accessed February 12, 2025. https:\/\/data.hrsa.gov\/topics\/healthcenters\/uds\/overview"},{"key":"yoi250052r32","unstructured":"SAS. SAS\/ETS 15.2 user\u2019s guide. Accessed June 30, 2024. https:\/\/documentation.sas.com\/doc\/en\/etsug\/15.2\/titlepage.htm"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2840223\/jamapsychiatry_fortney_2025_oi_250052_1764029655.24051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:00:44Z","timestamp":1764777644000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2840223"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2962","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}